A critical discovery in cancer investigation is occurring with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in several forms of tumors, resulting https://hylistings.com/story23341041/nanobodies-reactivate-the-p53-protein-new-potential-pathway-for-tumor-treatment